Sue Singer
Life sciences companies spend billions of dollars trying to guess why patients quietly stop a treatment or care plan. By the time they find out, the patient and the revenue are already gone.
Sue Singer built Salura to close that gap: a patient intelligence company that surfaces the why behind the reasons patients start, stay on, or stop treatment, and delivers it to life sciences and digital health companies in days, not months.
Before Salura, Sue spent more than 15 years in health tech, including helping scale Rally Health from roughly 40 employees to more than 2,000 ahead of its acquisition by UnitedHealth Group, and later serving as VP of Product at Lark Health. She holds an MBA from Darden. Sue founded Salura after her own experience as a breast cancer patient exposed a gap in care that current clinical data alone couldn't explain.